JOHNSON & JOHNSON is 397.9x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($573.71 B vs $1.44 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLS | JNJ |
|---|---|---|
| Market cap | $1.44 B | $573.71 B |
| US-listed rank | #2371 | #20 |
| Revenue (latest FY) | $0.00 | $94.19B |
| Net income (latest FY) | -$26.86M | $26.80B |
| Net margin | - | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 1,262 | 984 |
JOHNSON & JOHNSON is 397.9x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($573.71 B vs $1.44 B).
Full pages: SELLAS Life Sciences Group, Inc. and JOHNSON & JOHNSON, or browse the full rankings.